Literature DB >> 9159442

Treatment-related chromosome abnormalities in human embryos.

S Munne1, C Magli, A Adler, G Wright, K de Boer, D Mortimer, M Tucker, J Cohen, L Gianaroli.   

Abstract

Mosaicism was studied in good quality embryos from four different centres in order to assess the effects of follicular induction and exposure to laboratory conditions on chromosomal status. The donated embryos were fully biopsied and analysed by fluorescence in-situ hybridization using probes for chromosomes X, Y, 13, 18 and 21, simultaneously. The number of abnormal cells present indicated the division at which mosaicism first occurred (4/4 cells at first division, 2/4 cells at second, 2/8 at third). The rate of mosaicism in embryos from different centres varied greatly (P < 0.001). Most of the mosaic embryos were obtained before 1991. In one clinic increased mosaicism was found in embryos obtained before 1991 when compared to embryos obtained thereafter. The results suggest that certain culture conditions and/or hormonal stimulation protocols may induce chromosomal abnormalities and partly explain differences in pregnancy rates between in-vitro fertilization centres.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9159442     DOI: 10.1093/humrep/12.4.780

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  41 in total

1.  Preimplantation genetic diagnosis of aneuploidy: were we looking at the wrong chromosomes?

Authors:  M Bahçe; J Cohen; S Munné
Journal:  J Assist Reprod Genet       Date:  1999-04       Impact factor: 3.412

2.  Human embryos derived from in vitro and in vivo matured oocytes: analysis for chromosomal abnormalities and nuclear morphology.

Authors:  C DeScisciolo; D L Wright; J F Mayer; W Gibbons; S J Muasher; S E Lanzendorf
Journal:  J Assist Reprod Genet       Date:  2000-05       Impact factor: 3.412

Review 3.  Is there any evidence for immunologically mediated or immunologically modifiable early pregnancy failure?

Authors:  David A Clark
Journal:  J Assist Reprod Genet       Date:  2003-02       Impact factor: 3.412

4.  The relationship of pronuclear stage morphology and chromosome status at cleavage stage.

Authors:  Chun-Kai Chen; Guan-Yi Shen; Shang-Gwo Horng; Chia-Woei Wang; Hong-Yuan Huang; Hsin-Shin Wang; Yung-Kuei Soong
Journal:  J Assist Reprod Genet       Date:  2003-10       Impact factor: 3.412

5.  Objective assessments of temperature maintenance using in vitro culture techniques.

Authors:  Simon Cooke; John P P Tyler; Geoff Driscoll
Journal:  J Assist Reprod Genet       Date:  2002-08       Impact factor: 3.412

6.  Contributing factors for the incidence of aneuploidy in older patients undergoing intracytoplasmic sperm injection cycles.

Authors:  Daniela Paes de Almeida Ferreira Braga; Amanda S Setti; Rita de Cássia S Figueira; Assumpto Iaconelli; Edson Borges
Journal:  J Assist Reprod Genet       Date:  2012-05-29       Impact factor: 3.412

7.  The effects of IVF aspiration on the temperature, dissolved oxygen levels, and pH of follicular fluid.

Authors:  Gabe P Redding; John E Bronlund; Alan L Hart
Journal:  J Assist Reprod Genet       Date:  2006-03-15       Impact factor: 3.412

8.  Chromosome instability is common in human cleavage-stage embryos.

Authors:  Evelyne Vanneste; Thierry Voet; Cédric Le Caignec; Michèle Ampe; Peter Konings; Cindy Melotte; Sophie Debrock; Mustapha Amyere; Miikka Vikkula; Frans Schuit; Jean-Pierre Fryns; Geert Verbeke; Thomas D'Hooghe; Yves Moreau; Joris R Vermeesch
Journal:  Nat Med       Date:  2009-04-26       Impact factor: 53.440

9.  Mild IVF using GnRH agonist long protocol is possible: comparing stimulations with 100 IU vs. 150 IU recombinant FSH as starting dose.

Authors:  Sylvia Fernández-Shaw; Nuria Pérez Esturo; Rosa Cercas Duque; Isabel Pons Mallol
Journal:  J Assist Reprod Genet       Date:  2009-01-17       Impact factor: 3.412

10.  Detection of embryo sex chromosome by dual color fluorescent in-situ hybridization.

Authors:  Qun Liu; Guijin Zhu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.